Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201009703 Principal Investigator: DiPersio, John
Title: Phase II Trial of Vorinostat plus Tacrolimus & Mycophenolate to prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This is a clinical trial to see if the addition of vorinostat helps in preventing a major complication of hematopoietic cell transplantation called acute graft versus host disease (GVHD). The study’s main objective will be to see whether the addition of vorinostat to standard GVHD prevention medicines will decrease the rate of acute GVHD by 100 days following allogeneic HCT from related donors.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)